Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment

BACKGROUND: Smoking is one of well known environmental factors causing endothelial dysfunction and plays important role in the atherosclerosis. We investigated the effect of cilostazol could improve the endothelial dysfunction in smokers with the measurement of flow-mediated dilatation (FMD). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyu Seop, Park, Hyung Seo, Jung, Il Soon, Park, Jae-Hyeong, Ahn, Kye Taek, Jin, Seon-Ah, Park, Yong Kyu, Kim, Jun Hyung, Lee, Jae-Hwan, Choi, Si Wan, Jeong, Jin-Ok, Seong, In-Whan
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Echocardiography 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079080/
https://www.ncbi.nlm.nih.gov/pubmed/21519488
http://dx.doi.org/10.4250/jcu.2011.19.1.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079080/
https://www.ncbi.nlm.nih.gov/pubmed/21519488
http://dx.doi.org/10.4250/jcu.2011.19.1.21

Ejemplares similares